Orion Pharma Limited (DSE:ORIONPHARM)

Orion Pharma Revenue

Orion Pharma had revenue of 1.49B BDT in the quarter ending March 31, 2026, with 75.93% growth. This brings the company's revenue in the last twelve months to 3.01B, down -51.37% year-over-year. In the fiscal year ending June 30, 2025, Orion Pharma had annual revenue of 4.08B, down -61.57%.

• Revenue (ttm): 3.01B
• Revenue Growth: -51.37%
• P/S Ratio: 2.07
• Revenue / Employee: 1.02M
• Employees: 2,954
• Market Cap: 6.22B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	4.08B	-6.54B	-61.57%
Jun 30, 2024	10.62B	-3.31B	-23.74%
Jun 30, 2023	13.93B	4.26B	44.14%
Jun 30, 2022	9.66B	-1.17B	-10.81%
Jun 30, 2021	10.83B	3.18B	41.64%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 5, 2026

Data Sources Report a data error